Health care, biotech focus of upcoming Life Sciences Summit
The role of artificial intelligence in health care, trade and regulatory updates, and Utah’s health care are among the topics to be explored at the 2025 Mayer Brown Utah Life Sciences Summit, a BioUtah event taking place Nov. 12 in Salt Lake City.
The annual event will bring together executives, researchers, policymakers and entrepreneurs to discuss the future of health care and biotechnology.
The morning’s opening plenary session includes keynote speaker Melissa Holyoak, a commissioner of the U.S. Federal Trade Commission and a leader in consumer protection and constitutional law.
Other morning activities include a welcome from Kelvyn Cullimore, CEO of BioUtah; a chairman’s report from Mark Paul, executive director of the Center for Medical Innovation at University of Utah Health; Jefferson Moss, executive director of the Governor’s Office of Economic Opportunity and the Nucleus Institute, discussing “Life Sciences: A Targeted Industry”; a discussion about “AI Impacts in Health Care”; an “FDA Town Hall” with Michelle Tarver, director of the Center for Devices and Radiological Health at the U.S. Food and Drug Administration; a panel including David Bearss, president and CEO, Halia Therapeutics, Bob Carter, senior vice president for health sciences and CEO, University of Utah Health, and Mark Ott, inaugural dean, BYU School of Medicine, discussing “The Future of Healthcare in Utah: Navigating Costs, Care and the Coming Silver Tsunami”; Peter Marks, consultant, discussing “The Miracle of Modern Medicine”; and a panel presentation titled “National Security Commission on Emerging Biotechnology.”
Throughout the morning, industry contributors will be recognized with BioUtah’s annual awards.
Afternoon activities feature four tracks: “Regulatory and Quality,” focused on evolving FDA and HHS practices, AI’s role in life sciences regulation, clinical trial innovations, and FDA’s quality system harmonization efforts; “BioUtah,” focused on health care supply chain strategies, AI in life sciences research and development, health care reimbursement, social media for business growth, and Utah’s expanding life sciences ecosystem; “Workforce,” focused on Utah’s talent advantage, new workforce development tools, national and local labor perspectives, and immigration challenges facing the life sciences workforce; and “Legal,” focused on SEC perspectives on fundraising, term sheet negotiations, and the shifting landscape of patents, trade secrets and intellectual property law.
The summit takes place 8 a.m.-5 p.m. at Hilton Salt Lake City Center, 255 S. West Temple, Salt Lake City. The cost is $300 for BioUtah members, $400 for nonmembers, $100 for students. Discounted group tickets also are available.
The event website is https://utahlifesciencessummit.com/.